H. B. Fuller (NYSE:FUL – Get Free Report) was upgraded by stock analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a report issued on Sunday.
FUL has been the topic of several other reports. Weiss Ratings reiterated a “hold (c)” rating on shares of H. B. Fuller in a research report on Monday, December 29th. Citigroup decreased their target price on shares of H. B. Fuller from $76.00 to $67.00 and set a “buy” rating for the company in a research report on Thursday, March 19th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of H. B. Fuller in a research note on Friday, January 16th. UBS Group reduced their price objective on H. B. Fuller from $66.00 to $63.00 and set a “neutral” rating for the company in a research report on Friday. Finally, Vertical Research raised H. B. Fuller from a “hold” rating to a “strong-buy” rating in a report on Friday. One analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $64.75.
View Our Latest Research Report on FUL
H. B. Fuller Price Performance
H. B. Fuller (NYSE:FUL – Get Free Report) last posted its earnings results on Wednesday, March 25th. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.56 by $0.01. H. B. Fuller had a return on equity of 11.84% and a net margin of 4.62%.The company had revenue of $770.84 million for the quarter, compared to analysts’ expectations of $787.77 million. During the same period last year, the business posted $0.54 earnings per share. The firm’s quarterly revenue was down 2.3% compared to the same quarter last year. On average, research analysts forecast that H. B. Fuller will post 4.07 earnings per share for the current year.
Institutional Trading of H. B. Fuller
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Deprince Race & Zollo Inc. increased its stake in shares of H. B. Fuller by 80.4% during the third quarter. Deprince Race & Zollo Inc. now owns 555,877 shares of the specialty chemicals company’s stock valued at $32,952,000 after acquiring an additional 247,815 shares during the period. New York State Common Retirement Fund lifted its position in H. B. Fuller by 38.3% in the third quarter. New York State Common Retirement Fund now owns 149,448 shares of the specialty chemicals company’s stock worth $8,859,000 after purchasing an additional 41,365 shares during the period. JPMorgan Chase & Co. boosted its stake in H. B. Fuller by 16.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 612,048 shares of the specialty chemicals company’s stock valued at $36,815,000 after purchasing an additional 85,469 shares in the last quarter. Squarepoint Ops LLC bought a new position in H. B. Fuller during the 2nd quarter valued at $1,661,000. Finally, Luminus Management LLC acquired a new position in shares of H. B. Fuller during the 3rd quarter valued at $2,172,000. 95.93% of the stock is currently owned by institutional investors.
H. B. Fuller News Summary
Here are the key news stories impacting H. B. Fuller this week:
- Positive Sentiment: Company announced a global price hike of at least 10% starting April to address petrochemical supply constraints and rising input costs — a measure likely to help margins and cash flow. Article Title
- Positive Sentiment: Management issued FY guidance of $4.55–$4.90 in EPS and mid-single-digit revenue growth, signaling confidence that price actions and cost management will offset supply volatility. Article Title
- Positive Sentiment: Q1 EPS of $0.57 beat consensus ($0.56), and management reiterated improved profitability drivers; several outlets characterize the quarter as a solid start despite top-line pressure. Article Title
- Neutral Sentiment: Full earnings call transcript, slide deck and presentations are available for investors to review detailed segment results and management commentary. Earnings Call Transcript
- Negative Sentiment: Revenue missed estimates ($770.8M reported vs. ~$787.8M consensus) and was down 2.3% year-over-year, a near-term headwind for growth expectations. Article Title
- Negative Sentiment: UBS lowered its price target from $66 to $63 and moved to a neutral rating, which could cap upside momentum and signal analyst caution. Article Title
- Negative Sentiment: Some analysts expressed reduced optimism after the quarter, highlighting mixed signals (beat on EPS vs. weaker revenue and supply risks) that may keep multiple compression or volatility in place. Article Title
About H. B. Fuller
H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.
Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.
Recommended Stories
Receive News & Ratings for H. B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.
